Pascal Maisonobe

2.2k citations

87 papers · 1.6k indexed · h-index 21

Impact in

Neurology top 1%
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
Rehabilitation top 1%
- Stroke Rehabilitation and Recovery

Papers in ⓘ

Neurology 68
- Botulinum Toxin and Related Neurological Disorders 61
- Neurological disorders and treatments 18
- Parkinson's Disease Mechanisms and Treatments 12
Rehabilitation 29
- Stroke Rehabilitation and Recovery 29

Co-authors: David A. Cherry (1 shared paper)R. Sabatowski (1 shared paper)Mark Versavel (1 shared paper)Emmanuelle Vincent (1 shared paper)Rafael Gálvez (1 shared paper)Lynne Turner‐Stokes (17 shared papers)Klemens Fheodoroff (17 shared papers)Jorge Jacinto (18 shared papers)
Journals: Journal of Rehabilitation Medicine (7 papers)Toxicon (6 papers)Toxins (6 papers)BMJ Open (6 papers)Neurology (4 papers)
Partner nations: France United Kingdom Portugal

In The Last Decade

Pascal Maisonobe

80 papers receiving 1.6k citations

Peers

Countries citing papers authored by Pascal Maisonobe

Since Specialization

Citations

This map shows the geographic impact of Pascal Maisonobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Maisonobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Maisonobe more than expected).

Fields of papers citing papers by Pascal Maisonobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Maisonobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Maisonobe. The network helps show where Pascal Maisonobe may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Maisonobe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Maisonobe Line = papers co-authored together Pascal Maisonobe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial Pain ·R. Sabatowski, Rafael Gálvez, David A. Cherry, Florence Jacquot, Emmanuelle Vincent, Pascal Maisonobe, Mark Versavel	2004	397
2	Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial The Journal of Clinical Endocrinology & Metabolism ·Philippe Caron, John S. Bevan, Stephan Petersenn, Daniel Flanagan, Antoine Tabarin, Gaëtan Prévost, Pascal Maisonobe, Antoine Clermont, (unknown)	2013	134
3	Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke Neurorehabilitation and neural repair ·Raymond L. Rosales, Keng He Kong, Khean Jin Goh, Witsanu Kumthornthip, Vincent Mok, Mary Mildred Delgado-De Los Santos, Karen Sui Geok Chua, Saini Jeffery bin Freddy Abdullah, Benjamin Zakine, Pascal Maisonobe, Axel Magis, Ka Sing Wong	2012	90
4	Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management BMJ Open ·Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe	2013	78
5	Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study BMC Cancer ·Marta Martín-Richard, Bartomeu Massutí, Eva Margarita Pineda, Vicente Alonso, Maribel Mármol, Daniel Castellano, Emilio Fonseca, António Galán de Mera, Marta Llanos, María Ángeles Sala, Carles Pericay, Fernando Rivera, Javier Sastre, Ángel Segura, María Quindós, Pascal Maisonobe	2013	59
6	The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey International Journal of Rehabilitation Research ·A. M. O. Bakheit, Benjamin Zakine, Pascal Maisonobe, Claire Aymard, Klemens Fhedoroff, Harold Hefter, Jorge Jacinto, Wolfgang H. Jost, Franco Molteni, Henk J. Stam, Lynne Turner‐Stokes, Jörg Wissel	2010	58
7	Control of IGF‐I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly Clinical Endocrinology ·Philippe Chanson, Françoise Borson‐Chazot, Jean‐Marc Kuhn, Joëlle Blumberg, Pascal Maisonobe, Brigitte Delemer, (unknown)	2008	56
8	Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study BMJ Open ·V.P. Misra, Edvard Ehler, Benjamin Zakine, Pascal Maisonobe, M. Simonetta‐Moreau, (unknown)	2012	41
9	Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice BMJ Open ·Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe, Benjamin Zakine	2013	40
10	Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of Lanreotide 30 mg PR in the Treatment of Pancreatic and Enterocutaneous Fistulae Annals of Surgery ·François Gayral, Jean‐Pierre Campion, Jean‐Marc Regimbeau, Joëlle Blumberg, Pascal Maisonobe, Philippe Topart, Philippe Wind	2009	39
11	Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study Digestive and Liver Disease ·Philippe Ruszniewski, Juan W. Valle, Catherine Lombard‐Bohas, Daniel J. Cuthbertson, Petros Perros, L Holubec, Gianfranco Delle Fave, Denis Smith, Patricia Niccoli, Pascal Maisonobe, Philippe Atlan, Martyn Caplin	2016	39
12	Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study Journal of Clinical Oncology ·Pascale Mariani, Joëlle Blumberg, Alain Landau, Daniela Lebrun-Jezekova, Estelle Botton, Olivier Béatrix, Didier Mayeur, Robert Hervé, Pascal Maisonobe, L. Chauvenet	2012	37
13	Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study European Journal of Endocrinology ·Sebastian JCMM Neggers, Vyacheslav Pronin, Inga Balcere, Moon‐Kyu Lee, Liudmila Rozhinskaya, Marcello D. Bronstein, Mônica R. Gadelha, Pascal Maisonobe, Caroline Sert, Aart Jan van der Lely, (unknown)	2015	32
14	Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study Toxins ·Raymond L. Rosales, Jovita Balcaitiene, Hugues Berard, Pascal Maisonobe, Khean Jin Goh, Witsanu Kumthornthip, Mazlina Mazlan, Lydia Abdul Latif, Mary Mildred Delgado-Delos Santos, Chayaporn Chotiyarnwong, Phakamas Tanvijit, Odessa Setiota Nuez, Keng He Kong	2018	32
15	Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case–Control Study Advances in Therapy ·Charles Chapron, Jinghe Lang, Jinhua Leng, Yingfang Zhou, Xinmei Zhang, Min Xue, А.А. Popov, Vladimir Romanov, Pascal Maisonobe, Patrick Cabri	2016	31
16	Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III) BMJ Open ·Lynne Turner‐Stokes, Stephen Ashford, Jorge Jacinto, Pascal Maisonobe, Jovita Balcaitiene, Klemens Fheodoroff	2016	26
17	Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study Journal of Rehabilitation Medicine ·Lynne Turner‐Stokes, J Jacinto, Klemens Fheodoroff, Allison Brashear, Pascal Maisonobe, Andreas Lysandropoulos, STRATA Collaboration Group	2021	24
18	Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia Parkinsonism & Related Disorders ·Joaquim J. Ferreira, Carlo Colosimo, Roongroj Bhidayasiri, Marı́a José Martı́, Pascal Maisonobe, Savary Om	2014	23
19	How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study Journal of Neurology ·(unknown), Carlo Colosimo, David Charles, V.P. Misra, Pascal Maisonobe, Savary Om	2019	22
20	Evaluation of urinary prostate cancer antigen‐3 ( PCA 3) and TMPRSS 2‐ ERG score changes when starting androgen‐deprivation therapy with triptorelin 6‐month formulation in patients with locally advanced and metastatic prostate cancer British Journal of Urology ·Luis Martínez‐Piñeiro, Jack A. Schalken, Patrick Cabri, Pascal Maisonobe, Alexandre de la Taille, (unknown)	2013	21

About Pascal Maisonobe

Pascal Maisonobe is a scholar working on Neurology, Rehabilitation, Psychiatry and Mental health, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 87 papers that have together received 1.6k indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (61 papers), Stroke Rehabilitation and Recovery (29 papers), Neurological disorders and treatments (18 papers), Cerebral Palsy and Movement Disorders (18 papers), Hereditary Neurological Disorders (16 papers), Parkinson's Disease Mechanisms and Treatments (12 papers), Neuroendocrine Tumor Research Advances (10 papers) and Pain Mechanisms and Treatments (9 papers). The work is most often cited by research in Neurology (898 citations), Rehabilitation (317 citations), Psychiatry and Mental health (289 citations), Anesthesiology and Pain Medicine (95 citations) and Endocrinology, Diabetes and Metabolism (264 citations). Pascal Maisonobe has collaborated with scholars based in France, United Kingdom and Portugal. Frequent co-authors include David A. Cherry, R. Sabatowski, Mark Versavel, Emmanuelle Vincent, Rafael Gálvez, Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Benjamin Zakine and V.P. Misra. Their work appears in journals such as Journal of Rehabilitation Medicine, Toxicon, Toxins, BMJ Open and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact